Our drug pricing and pharmacy solutions can analyze and monitor drug utilization patterns that allow Part D plan sponsors to respond rapidly to changes in the pharmaceutical marketplace.
Qlarant’s Post
More Relevant Posts
-
As the U.S. pharmaceutical landscape continues to evolve, biosimilars are one of the biggest opportunities for reducing drug costs for employers and consumers. Check out this post about our evolving pharmacy strategy!
To view or add a comment, sign in
-
Country Manager. Authored - 'You Can Be A Medical Representative' and 'To Command Is To Serve - That's A True Pharma First-Line Leader"
IMPORTANCE OF PRESCRIPTION 1. The health of a Pharma Company depends on the number of prescriptions that the sales people able to generate. 2.Prescription produces revenue for the Company. Market is very dynamic, without continuous new prescription pharmaceutical business declines 3..Building a brand is nothing but generating more and more prescriptions. Your Thoughts!
To view or add a comment, sign in
-
Conclusion The interplay of PBMs, wholesalers, GPOs, PSAOs, and various pricing practices creates a complex environment that leads to increased costs for brand-name drugs in the U.S. In contrast, the international pricing data demonstrates significant variations in drug costs across countries, often influenced by differing regulatory environments and market dynamics. This information underscores the need for continued discussions about pharmaceutical pricing reform and transparency.
To view or add a comment, sign in
-
Yesterday, I had the opportunity to attend the FDA Drug Topics Webinar on The Bad Ad Program, led by Adesola "Sola" Adejuwon, PharmD, MBA. Did you know that almost 68% of prescription drug ads target healthcare professionals rather than patients? This session offered valuable insights into how these ads are regulated—a critical aspect of pharmaceutical marketing. I'm excited to apply this knowledge to the translation work we do, ensuring clear and effective communication for pharmaceutical companies. #PharmaceuticalIndustry #DrugRegulation #TranslationServices #LanguageAccess #FDA
To view or add a comment, sign in
-
Our latest report shares insights into the impact of major pharmaceutical companies leaving the market and explores actionable recommendations to strengthen local pharmaceutical production and improve healthcare resilience. Download the white paper and get commercial insights on drug price changes in 2024. https://lnkd.in/duuapdwZ #DrugShortages #HealthcareAccess #OneHealth
To view or add a comment, sign in
-
Consider this: Do you see more ads for prescription medications or over-the-counter drugs lately? 💊 Believe it or not, prescription drugs totaled 90 percent of pharmaceutical ad spend in Q1-Q3 2023, steering the pharma sector at large. Not to mention, prescription drug ad spend growth gained momentum year over year. How does this affect your media planning strategy for the upcoming quarter? You can find more actionable insights to build your plan with Guideline. https://hubs.la/Q02kHWRv0 #pharmaceuticals #PharmaMediaPlanning #AdSpendTrends2023
To view or add a comment, sign in
-
Pharmaceutical giants are joining direct-to-consumer drug programs one by one. Programs like LillyDirect and PfizerForAll have already been announced. I hope this will benefit patients, especially if regulations take into account both patient needs and the pharmaceutical industry. It would also be helpful if drug marketing materials, presenting expected positive treatment outcomes, were accompanied by explanatory and educational resources, like the ones we create at Voka. The video illustrate functioning of the Tricuspid Valve. #PharmaInnovation #PatientCareSolutions #DirectToConsumer #HealthcareRegulation #MedicalEducation #PharmaTech #PatientCenteredCare #DigitalHealth #PatientEngagement #vokaio
To view or add a comment, sign in
-
In the pharmaceutical industry, maintaining the quality and compliance of drug products is crucial for ensuring patient safety and meeting regulatory requirements. One key process in achieving this is the Annual Drug Product Review (ADPR). This review is a systematic evaluation of a drug product’s performance and compliance over the course of a year. This blog discusses why the Annual Drug Product Review is essential, its core components, and how it contributes to effective quality management. Read more here: https://lnkd.in/d4PgksKq
To view or add a comment, sign in
-
#PBM Money Flow Explained... Let's Review How Pharmacy Benefits Managers Are #Paid. #PharmacyBenefitManagers (PBMs) process prescription claims for health plans This video explains the #prescription medication ecosystem in a simple chart that Every #EmployeeBenefits Professional should be able to reproduce from MEMORY. Prescription Medication Ecosystem Members Include: 1. #PlanSponsor 2. #HealthPlan 3. PBM 4. Pharmaceutical #Manufacturer 5. Drug #Wholesaler 6. #Pharmacy 7. #Patient In short, the money flows from Plan Sponsor to Health Plan to PBM to Pharmacy to Drug Wholesaler to Pharmaceutical Manufacturer. The prescription medications flow from the Pharmaceutical Manufacturer to the Drug Wholesaler to the Pharmacy to the Patient. Sources at AHealthcareZ YouTube Channel.
To view or add a comment, sign in
3,200 followers